Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: KBV Research | PRODUCT CODE: 1245693

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1245693

Global Cluster Headache Market Size, Share & Industry Trends Analysis Report By Distribution channel, By Type (Episodic, and Chronic), By Drug Class (Triptans, Calcium Channel Blockers, Ergot Derivatives), By Regional Outlook and Forecast, 2022 - 2028

PUBLISHED:
PAGES: 201 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 3600
PDF (Site License)
USD 4320
PDF (Enterprisewide License)
USD 6048

Add to Cart

Description

Table of Contents

List of Tables

The Global Cluster Headache Market size is expected to reach $437.5 Million by 2028, rising at a market growth of 4.0% CAGR during the forecast period.

Cluster headaches are the most prevalent among the primary trigeminal autonomic cephalgia headache forms. These headaches might happen once every two days to eight times each day, just like other trigeminal autonomic cephalgias. These happen around the same time of day, most frequently at night. Most patients experience attacks daily for weeks to months, followed by remission lasting months to years. A cluster headache is a transient unilateral headache.

Depending on how long a cluster headache lasts, it might be classified as either episodic or chronic. Chronic cluster headache attacks last more than a year without remission or less than two weeks. Cluster headaches start suddenly and without any prior pain. On one side of the head, the pain is intense and frequently characterized as searing, burning, or piercing. It is frequently felt near the eye, temple, and occasionally the cheek.

During each strike, it often targets the same side. Because of how intense the pain is during an attack; people frequently feel restless and agitated and may respond by rocking or pacing their heads. Although the precise etiology of cluster headaches is unknown, they have been associated with activity in the hypothalamus, a brain region. Smokers appear to be more susceptible to developing cluster headaches.

There may be a hereditary relationship between cluster headaches and other family members for certain people who get them. A cluster headache episode may occasionally be brought on by consuming alcohol or inhaling strong odors like paint, perfume, or gasoline. During the symptom-free phase (remission), the headaches may go away for weeks, months, or even years before returning.

COVID-19 Impact Analysis

Headaches from COVID-19 are a sign of systemic viral infections and a headache does not aid the diagnosis or prognosis of COVID-19 infection. Headache is a symptom of COVID-19 infection, which frequently coexists with fever and may even be reliant upon it. Also, long COVID-19 headaches may manifest as a main headache that has already started to worsen or, more precisely, as a new (intermittent or daily) headache that begins during the acute infection or after a delay. Thus, a rising occurrence of headaches in pandemic-infected individuals is projected to drive market expansion.

Market Growth Factors

Increase in cluster headache frequency

the cluster headache patterns point to the hypothalamus, the body's circadian clock, as a potential contraibuting factor. Unlike migraine and tension headaches, cluster headache is typically not brought on by triggers such as certain meals, hormonal changes, or stress. Yet, consuming alcohol could swiftly create a splitting headache once a cluster phase starts. The usage of drugs like nitroglycerin, a prescription used to treat heart problems, is another potential cause. The growing prevalence of cluster headaches due to changing lifestyles and the consumption of some drugs or alcohol will propel the market growth.

Improvements in medication research and available treatments

Natural compounds and their structural analogs have significantly influenced pharmacology. Recent advancements in technology and science, including enhanced analytical tools, genome mining and engineering techniques, and improvements in microbial culture, are tackling existing issues and creating new possibilities. To combat antimicrobial resistance, this has revived interest in natural compounds as drug leads. The use of natural compounds and the increasing pharmaceutical-based R&D will enhance the effectiveness of the cluster headache medications, which will drive the market expansion.

Market Restraining Factors

Limited knowledge of the condition

Cluster headaches have no known permanent cure, and the other treatments are aimed at lessening pain intensity, minimizing the duration of the headache, and stopping episodes. Because they require quick-acting medications and their pain may arise suddenly and vanish swiftly, cluster headaches can be difficult to detect and treat. The exact etiology of cluster headaches is unknown. Cluster headaches are not subject to any tests. A doctor will often make a diagnosis by investigating a patient's symptoms and headache history and usually keep a headache journal with a list of symptoms that might be useful.

Drug Class Outlook

Based on drug class, the cluster headache market is segmented into ergot derivatives, calcium channel blockers, triptans and others. The triptans segment dominated the cluster headache market with the maximum revenue share in 2021. This is because they are a class, or group, of medicines that can stop migraine episodes. These drugs work to lessen symptoms by constricting enlarged blood arteries in the brain brought on by migraine attacks. Also, they are present in several dose formulations. Depending on the symptoms, the doctor may recommend a different dose type, like the doctor could recommend a nasal spray rather than tablets to ingest if the patient is experiencing nausea and vomiting along with the migraine.

Distribution Channel Outlook

On the basis of distribution channel, the cluster headache market is divided into hospital pharmacies, drug stores & retail pharmacies and others. The drug stores & retail pharmacies segment held the highest revenue share in the cluster headache market in 2021. The growth is owing to a rise in consumer preference for retail pharmacies, which offer advice on drugs and their use throughout treatment periods. They offer first-rate customer service, affordable prices, and a large variety of general healthcare and home goods. Local pharmacists can also provide one-on-one consultations and guidance right away.

Type Outlook

By type, the cluster headache market is classified into episodic and chronic. The chronic segment garnered a prominent revenue share in the cluster headache market in 2021. This is due to the fact that most people with cluster headaches suffer from the chronic kind. Chronic cluster headaches might develop from the episodic form over time, or they can be present from the start, which drives the segment's expansion. Like cluster headaches, chronic paroxysmal hemicrania (CPH) condition has shorter-lasting and more frequent symptoms, further expanding the segment growth.

Regional Outlook

Region-wise, the cluster headache market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the cluster headache market in 2021. This growth is owing to an increase in cluster headache instances in the region. In addition, there is an increase in major players offering innovative therapies and the presence of improved healthcare infrastructure. With a thriving sophisticated healthcare infrastructure, and the introduction of cutting-edge technology to detect illness, the market is anticipated to propel during the projected period.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy's Laboratories Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC (GSK), Pfizer, Inc., Fresenius SE & Co. KGaA, Eli Lilly And Company, Grunenthal GmbH, and Arrotex Pharmaceuticals Pty Limited.

Scope of the Study

Market Segments covered in the Report:

By Distribution channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Others

By Type

  • Episodic
  • Chronic

By Drug Class

  • Triptans
  • Calcium Channel Blockers
  • Ergot Derivatives
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Dr. Reddy's Laboratories Ltd.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Fresenius SE & Co. KGaA
  • Eli Lilly And Company
  • Grunenthal GmbH
  • Arrotex Pharmaceuticals Pty Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Show more

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cluster Headache Market, by Distribution channel
    • 1.4.2 Global Cluster Headache Market, by Type
    • 1.4.3 Global Cluster Headache Market, by Drug Class
    • 1.4.4 Global Cluster Headache Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Cluster Headache Market by Distribution channel

  • 3.1 Global Drug Stores & Retail Pharmacies Market by Region
  • 3.2 Global Hospital Pharmacies Market by Region
  • 3.3 Global Others Market by Region

Chapter 4. Global Cluster Headache Market by Type

  • 4.1 Global Episodic Market by Region
  • 4.2 Global Chronic Market by Region

Chapter 5. Global Cluster Headache Market by Drug Class

  • 5.1 Global Triptans Market by Region
  • 5.2 Global Calcium Channel Blockers Market by Region
  • 5.3 Global Ergot Derivatives Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global Cluster Headache Market by Region

  • 6.1 North America Cluster Headache Market
    • 6.1.1 North America Cluster Headache Market by Distribution channel
      • 6.1.1.1 North America Drug Stores & Retail Pharmacies Market by Country
      • 6.1.1.2 North America Hospital Pharmacies Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Cluster Headache Market by Type
      • 6.1.2.1 North America Episodic Market by Country
      • 6.1.2.2 North America Chronic Market by Country
    • 6.1.3 North America Cluster Headache Market by Drug Class
      • 6.1.3.1 North America Triptans Market by Country
      • 6.1.3.2 North America Calcium Channel Blockers Market by Country
      • 6.1.3.3 North America Ergot Derivatives Market by Country
      • 6.1.3.4 North America Others Market by Country
    • 6.1.4 North America Cluster Headache Market by Country
      • 6.1.4.1 US Cluster Headache Market
        • 6.1.4.1.1 US Cluster Headache Market by Distribution channel
        • 6.1.4.1.2 US Cluster Headache Market by Type
        • 6.1.4.1.3 US Cluster Headache Market by Drug Class
      • 6.1.4.2 Canada Cluster Headache Market
        • 6.1.4.2.1 Canada Cluster Headache Market by Distribution channel
        • 6.1.4.2.2 Canada Cluster Headache Market by Type
        • 6.1.4.2.3 Canada Cluster Headache Market by Drug Class
      • 6.1.4.3 Mexico Cluster Headache Market
        • 6.1.4.3.1 Mexico Cluster Headache Market by Distribution channel
        • 6.1.4.3.2 Mexico Cluster Headache Market by Type
        • 6.1.4.3.3 Mexico Cluster Headache Market by Drug Class
      • 6.1.4.4 Rest of North America Cluster Headache Market
        • 6.1.4.4.1 Rest of North America Cluster Headache Market by Distribution channel
        • 6.1.4.4.2 Rest of North America Cluster Headache Market by Type
        • 6.1.4.4.3 Rest of North America Cluster Headache Market by Drug Class
  • 6.2 Europe Cluster Headache Market
    • 6.2.1 Europe Cluster Headache Market by Distribution channel
      • 6.2.1.1 Europe Drug Stores & Retail Pharmacies Market by Country
      • 6.2.1.2 Europe Hospital Pharmacies Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Cluster Headache Market by Type
      • 6.2.2.1 Europe Episodic Market by Country
      • 6.2.2.2 Europe Chronic Market by Country
    • 6.2.3 Europe Cluster Headache Market by Drug Class
      • 6.2.3.1 Europe Triptans Market by Country
      • 6.2.3.2 Europe Calcium Channel Blockers Market by Country
      • 6.2.3.3 Europe Ergot Derivatives Market by Country
      • 6.2.3.4 Europe Others Market by Country
    • 6.2.4 Europe Cluster Headache Market by Country
      • 6.2.4.1 Germany Cluster Headache Market
        • 6.2.4.1.1 Germany Cluster Headache Market by Distribution channel
        • 6.2.4.1.2 Germany Cluster Headache Market by Type
        • 6.2.4.1.3 Germany Cluster Headache Market by Drug Class
      • 6.2.4.2 UK Cluster Headache Market
        • 6.2.4.2.1 UK Cluster Headache Market by Distribution channel
        • 6.2.4.2.2 UK Cluster Headache Market by Type
        • 6.2.4.2.3 UK Cluster Headache Market by Drug Class
      • 6.2.4.3 France Cluster Headache Market
        • 6.2.4.3.1 France Cluster Headache Market by Distribution channel
        • 6.2.4.3.2 France Cluster Headache Market by Type
        • 6.2.4.3.3 France Cluster Headache Market by Drug Class
      • 6.2.4.4 Russia Cluster Headache Market
        • 6.2.4.4.1 Russia Cluster Headache Market by Distribution channel
        • 6.2.4.4.2 Russia Cluster Headache Market by Type
        • 6.2.4.4.3 Russia Cluster Headache Market by Drug Class
      • 6.2.4.5 Spain Cluster Headache Market
        • 6.2.4.5.1 Spain Cluster Headache Market by Distribution channel
        • 6.2.4.5.2 Spain Cluster Headache Market by Type
        • 6.2.4.5.3 Spain Cluster Headache Market by Drug Class
      • 6.2.4.6 Italy Cluster Headache Market
        • 6.2.4.6.1 Italy Cluster Headache Market by Distribution channel
        • 6.2.4.6.2 Italy Cluster Headache Market by Type
        • 6.2.4.6.3 Italy Cluster Headache Market by Drug Class
      • 6.2.4.7 Rest of Europe Cluster Headache Market
        • 6.2.4.7.1 Rest of Europe Cluster Headache Market by Distribution channel
        • 6.2.4.7.2 Rest of Europe Cluster Headache Market by Type
        • 6.2.4.7.3 Rest of Europe Cluster Headache Market by Drug Class
  • 6.3 Asia Pacific Cluster Headache Market
    • 6.3.1 Asia Pacific Cluster Headache Market by Distribution channel
      • 6.3.1.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
      • 6.3.1.2 Asia Pacific Hospital Pharmacies Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Cluster Headache Market by Type
      • 6.3.2.1 Asia Pacific Episodic Market by Country
      • 6.3.2.2 Asia Pacific Chronic Market by Country
    • 6.3.3 Asia Pacific Cluster Headache Market by Drug Class
      • 6.3.3.1 Asia Pacific Triptans Market by Country
      • 6.3.3.2 Asia Pacific Calcium Channel Blockers Market by Country
      • 6.3.3.3 Asia Pacific Ergot Derivatives Market by Country
      • 6.3.3.4 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Cluster Headache Market by Country
      • 6.3.4.1 China Cluster Headache Market
        • 6.3.4.1.1 China Cluster Headache Market by Distribution channel
        • 6.3.4.1.2 China Cluster Headache Market by Type
        • 6.3.4.1.3 China Cluster Headache Market by Drug Class
      • 6.3.4.2 Japan Cluster Headache Market
        • 6.3.4.2.1 Japan Cluster Headache Market by Distribution channel
        • 6.3.4.2.2 Japan Cluster Headache Market by Type
        • 6.3.4.2.3 Japan Cluster Headache Market by Drug Class
      • 6.3.4.3 India Cluster Headache Market
        • 6.3.4.3.1 India Cluster Headache Market by Distribution channel
        • 6.3.4.3.2 India Cluster Headache Market by Type
        • 6.3.4.3.3 India Cluster Headache Market by Drug Class
      • 6.3.4.4 South Korea Cluster Headache Market
        • 6.3.4.4.1 South Korea Cluster Headache Market by Distribution channel
        • 6.3.4.4.2 South Korea Cluster Headache Market by Type
        • 6.3.4.4.3 South Korea Cluster Headache Market by Drug Class
      • 6.3.4.5 Singapore Cluster Headache Market
        • 6.3.4.5.1 Singapore Cluster Headache Market by Distribution channel
        • 6.3.4.5.2 Singapore Cluster Headache Market by Type
        • 6.3.4.5.3 Singapore Cluster Headache Market by Drug Class
      • 6.3.4.6 Malaysia Cluster Headache Market
        • 6.3.4.6.1 Malaysia Cluster Headache Market by Distribution channel
        • 6.3.4.6.2 Malaysia Cluster Headache Market by Type
        • 6.3.4.6.3 Malaysia Cluster Headache Market by Drug Class
      • 6.3.4.7 Rest of Asia Pacific Cluster Headache Market
        • 6.3.4.7.1 Rest of Asia Pacific Cluster Headache Market by Distribution channel
        • 6.3.4.7.2 Rest of Asia Pacific Cluster Headache Market by Type
        • 6.3.4.7.3 Rest of Asia Pacific Cluster Headache Market by Drug Class
  • 6.4 LAMEA Cluster Headache Market
    • 6.4.1 LAMEA Cluster Headache Market by Distribution channel
      • 6.4.1.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
      • 6.4.1.2 LAMEA Hospital Pharmacies Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Cluster Headache Market by Type
      • 6.4.2.1 LAMEA Episodic Market by Country
      • 6.4.2.2 LAMEA Chronic Market by Country
    • 6.4.3 LAMEA Cluster Headache Market by Drug Class
      • 6.4.3.1 LAMEA Triptans Market by Country
      • 6.4.3.2 LAMEA Calcium Channel Blockers Market by Country
      • 6.4.3.3 LAMEA Ergot Derivatives Market by Country
      • 6.4.3.4 LAMEA Others Market by Country
    • 6.4.4 LAMEA Cluster Headache Market by Country
      • 6.4.4.1 Brazil Cluster Headache Market
        • 6.4.4.1.1 Brazil Cluster Headache Market by Distribution channel
        • 6.4.4.1.2 Brazil Cluster Headache Market by Type
        • 6.4.4.1.3 Brazil Cluster Headache Market by Drug Class
      • 6.4.4.2 Argentina Cluster Headache Market
        • 6.4.4.2.1 Argentina Cluster Headache Market by Distribution channel
        • 6.4.4.2.2 Argentina Cluster Headache Market by Type
        • 6.4.4.2.3 Argentina Cluster Headache Market by Drug Class
      • 6.4.4.3 UAE Cluster Headache Market
        • 6.4.4.3.1 UAE Cluster Headache Market by Distribution channel
        • 6.4.4.3.2 UAE Cluster Headache Market by Type
        • 6.4.4.3.3 UAE Cluster Headache Market by Drug Class
      • 6.4.4.4 Saudi Arabia Cluster Headache Market
        • 6.4.4.4.1 Saudi Arabia Cluster Headache Market by Distribution channel
        • 6.4.4.4.2 Saudi Arabia Cluster Headache Market by Type
        • 6.4.4.4.3 Saudi Arabia Cluster Headache Market by Drug Class
      • 6.4.4.5 South Africa Cluster Headache Market
        • 6.4.4.5.1 South Africa Cluster Headache Market by Distribution channel
        • 6.4.4.5.2 South Africa Cluster Headache Market by Type
        • 6.4.4.5.3 South Africa Cluster Headache Market by Drug Class
      • 6.4.4.6 Nigeria Cluster Headache Market
        • 6.4.4.6.1 Nigeria Cluster Headache Market by Distribution channel
        • 6.4.4.6.2 Nigeria Cluster Headache Market by Type
        • 6.4.4.6.3 Nigeria Cluster Headache Market by Drug Class
      • 6.4.4.7 Rest of LAMEA Cluster Headache Market
        • 6.4.4.7.1 Rest of LAMEA Cluster Headache Market by Distribution channel
        • 6.4.4.7.2 Rest of LAMEA Cluster Headache Market by Type
        • 6.4.4.7.3 Rest of LAMEA Cluster Headache Market by Drug Class

Chapter 7. Company Profiles

  • 7.1 Dr. Reddy's Laboratories Ltd.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Novartis AG
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
  • 7.3 Sun Pharmaceutical Industries Ltd.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional & Segmental Analysis
    • 7.3.4 Research & Development Expenses
  • 7.4 Teva Pharmaceutical Industries Ltd.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expenses
  • 7.5 GlaxoSmithKline PLC (GSK)
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Pfizer, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Regional & Segmental Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Fresenius SE & Co. KGaA
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expenses
  • 7.8 Eli Lilly And Company
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expenses
  • 7.9 Grunenthal GmbH
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expenses
  • 7.10. Arrotex Pharmaceuticals Pty Limited
    • 7.10.1 Company Overview
Show more

LIST OF TABLES

  • TABLE 1 Global Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 2 Global Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 3 Global Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 4 Global Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 5 Global Drug Stores & Retail Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Drug Stores & Retail Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 12 Global Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 13 Global Episodic Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Episodic Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Chronic Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Chronic Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 18 Global Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 19 Global Triptans Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Triptans Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Calcium Channel Blockers Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Calcium Channel Blockers Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Ergot Derivatives Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Ergot Derivatives Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Cluster Headache Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Cluster Headache Market by Region, 2022 - 2028, USD Million
  • TABLE 29 North America Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 30 North America Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 31 North America Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 32 North America Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 33 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 40 North America Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 41 North America Episodic Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Episodic Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Chronic Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Chronic Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 46 North America Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 47 North America Triptans Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Triptans Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Ergot Derivatives Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Ergot Derivatives Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Cluster Headache Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Cluster Headache Market by Country, 2022 - 2028, USD Million
  • TABLE 57 US Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 58 US Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 59 US Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 60 US Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 61 US Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 62 US Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 63 US Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 64 US Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 65 Canada Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 66 Canada Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 67 Canada Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 68 Canada Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 69 Canada Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 70 Canada Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 71 Canada Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 72 Canada Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 73 Mexico Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 74 Mexico Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 75 Mexico Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 76 Mexico Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 77 Mexico Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 78 Mexico Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 79 Mexico Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 80 Mexico Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 89 Europe Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 90 Europe Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 91 Europe Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 92 Europe Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 93 Europe Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 100 Europe Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 101 Europe Episodic Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Episodic Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Chronic Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Chronic Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 106 Europe Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 107 Europe Triptans Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Triptans Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Ergot Derivatives Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Ergot Derivatives Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Cluster Headache Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Cluster Headache Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Germany Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 118 Germany Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 119 Germany Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 120 Germany Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 121 Germany Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 122 Germany Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 123 Germany Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 124 Germany Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 125 UK Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 126 UK Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 127 UK Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 128 UK Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 129 UK Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 130 UK Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 131 UK Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 132 UK Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 133 France Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 134 France Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 135 France Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 136 France Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 137 France Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 138 France Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 139 France Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 140 France Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 141 Russia Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 142 Russia Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 143 Russia Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 144 Russia Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 145 Russia Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 146 Russia Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 147 Russia Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 148 Russia Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 149 Spain Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 150 Spain Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 151 Spain Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 152 Spain Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 153 Spain Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 154 Spain Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 155 Spain Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 156 Spain Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 157 Italy Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 158 Italy Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 159 Italy Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 160 Italy Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 161 Italy Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 162 Italy Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 163 Italy Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 164 Italy Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 165 Rest of Europe Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 166 Rest of Europe Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 167 Rest of Europe Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 168 Rest of Europe Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 169 Rest of Europe Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 170 Rest of Europe Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Episodic Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Episodic Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Chronic Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Chronic Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Triptans Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Triptans Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Ergot Derivatives Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Ergot Derivatives Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Cluster Headache Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Cluster Headache Market by Country, 2022 - 2028, USD Million
  • TABLE 201 China Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 202 China Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 203 China Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 204 China Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 205 China Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 206 China Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 207 China Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 208 China Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 209 Japan Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 210 Japan Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 211 Japan Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 212 Japan Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 213 Japan Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 214 Japan Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 215 Japan Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 216 Japan Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 217 India Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 218 India Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 219 India Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 220 India Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 221 India Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 222 India Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 223 India Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 224 India Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 225 South Korea Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 226 South Korea Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 227 South Korea Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 228 South Korea Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 229 South Korea Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 230 South Korea Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 231 South Korea Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 232 South Korea Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 233 Singapore Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 234 Singapore Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 235 Singapore Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 236 Singapore Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 237 Singapore Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 238 Singapore Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 239 Singapore Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 240 Singapore Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 241 Malaysia Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 242 Malaysia Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 243 Malaysia Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 244 Malaysia Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 245 Malaysia Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 246 Malaysia Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 247 Malaysia Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 248 Malaysia Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 249 Rest of Asia Pacific Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 250 Rest of Asia Pacific Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 251 Rest of Asia Pacific Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 252 Rest of Asia Pacific Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 253 Rest of Asia Pacific Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 254 Rest of Asia Pacific Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 255 Rest of Asia Pacific Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 256 Rest of Asia Pacific Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Episodic Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Episodic Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Chronic Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Chronic Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Triptans Market by Country, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Triptans Market by Country, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Ergot Derivatives Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Ergot Derivatives Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Cluster Headache Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Cluster Headache Market by Country, 2022 - 2028, USD Million
  • TABLE 285 Brazil Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 286 Brazil Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 287 Brazil Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 288 Brazil Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 289 Brazil Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 290 Brazil Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 291 Brazil Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 292 Brazil Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 293 Argentina Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 294 Argentina Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 295 Argentina Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 296 Argentina Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 297 Argentina Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 298 Argentina Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 299 Argentina Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 300 Argentina Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 301 UAE Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 302 UAE Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 303 UAE Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 304 UAE Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 305 UAE Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 306 UAE Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 307 UAE Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 308 UAE Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 309 Saudi Arabia Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 310 Saudi Arabia Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 311 Saudi Arabia Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 312 Saudi Arabia Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 313 Saudi Arabia Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 314 Saudi Arabia Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 315 Saudi Arabia Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 316 Saudi Arabia Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 317 South Africa Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 318 South Africa Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 319 South Africa Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 320 South Africa Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 321 South Africa Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 322 South Africa Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 323 South Africa Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 324 South Africa Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 325 Nigeria Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 326 Nigeria Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 327 Nigeria Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 328 Nigeria Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 329 Nigeria Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 330 Nigeria Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 331 Nigeria Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 332 Nigeria Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 333 Rest of LAMEA Cluster Headache Market, 2018 - 2021, USD Million
  • TABLE 334 Rest of LAMEA Cluster Headache Market, 2022 - 2028, USD Million
  • TABLE 335 Rest of LAMEA Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
  • TABLE 336 Rest of LAMEA Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
  • TABLE 337 Rest of LAMEA Cluster Headache Market by Type, 2018 - 2021, USD Million
  • TABLE 338 Rest of LAMEA Cluster Headache Market by Type, 2022 - 2028, USD Million
  • TABLE 339 Rest of LAMEA Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 340 Rest of LAMEA Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 341 key information - Dr. Reddy's Laboratories Ltd.
  • TABLE 342 Key Information - Novartis AG
  • TABLE 343 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 344 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 345 Key Information - GlaxoSmithKline PLC (GSK)
  • TABLE 346 Key Information - Pfizer, Inc.
  • TABLE 347 key information - Fresenius SE & Co. KGaA
  • TABLE 348 Key Information - Eli Lilly And Company
  • TABLE 349 Key Information - Grunenthal GmbH
  • TABLE 350 Key Information - Arrotex Pharmaceuticals Pty Limited

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Cluster Headache Market share by Distribution channel, 2021
  • FIG 3 Global Cluster Headache Market share by Distribution channel, 2028
  • FIG 4 Global Cluster Headache Market by Distribution channel, 2018 - 2028, USD Million
  • FIG 5 Global Cluster Headache Market share by Type, 2021
  • FIG 6 Global Cluster Headache Market share by Type, 2028
  • FIG 7 Global Cluster Headache Market by Type, 2018 - 2028, USD Million
  • FIG 8 Global Cluster Headache Market share by Drug Class, 2021
  • FIG 9 Global Cluster Headache Market share by Drug Class, 2028
  • FIG 10 Global Cluster Headache Market by Drug Class, 2018 - 2028, USD Million
  • FIG 11 Global Cluster Headache Market share by Region, 2021
  • FIG 12 Global Cluster Headache Market share by Region, 2028
  • FIG 13 Global Cluster Headache Market by Region, 2018 - 2028, USD Million
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!